Chris, I loved your article, and like many here, believe that a great injustice has occurred which has damaged this company and delayed a potentially "game changing" drug from getting to market sooner and helping many people that are in desperate need of help.
There are many Frustrated posters here that do nothing but ridicule the company, it's products and its BOD, regardless of any positive news. By the same token, there are other "connect the dots" posters that will espouse the great merits of this company regardless of their lack of progress or no matter how bad they screw up. Most readers ignore or gloss over both of these camps.
I tend to think of myself as more in the middle and will both defend and criticize what I see as positives and negatives of PPHM. I meant no offense but presenting conflicting information such as you did lends support to the naysayers when it comes to you presenting unbiased information and articles.
I am hoping (as many have suggested here) that our +10% rise last week was a combination of the information presented in your article (which I thank you for) and other as yet unforeseen developments which may become public knowledge in the near term future. If indeed the rise was strictly due to your article, then I fear we will give these gains back in the short term future.
Market Data 
Markets 
AI
